{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"15"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"22"}],"units":"Participants"}],"description":"The number of response rates in Lens Refractory participants that have achieved MR, PR, VGPR, CR","groups":[{"description":"All patients received oral panobinostat, lenalidomide and dexamethasone as per protocol","id":"OG000","title":"Panobinostat, Lenalidomide and Dexamethasone"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Only Len Refractory Patients","reportingStatus":"POSTED","timeFrame":"up to 4 years","title":"Clinical Benefit Rate for Len Refractory Patients","type":"SECONDARY","unitOfMeasure":"Participants"}